Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:e9037-e9038
doi: 10.1161/01.CIR.0000040100.60396.9F
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SoRelle, R.

(Circulation. 2002;106:e9037.)
© 2002 American Heart Association, Inc.

Cardiovascular News

Ruth SoRelle, MPH

Circulation Newswriter


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Increases in Urinary Albumin Excretion Predict Risk of Death From All Cases as Well as Those From Cardiovascular Disease

Urinary excretion of albumin predicts an increased risk of all-cause mortality, particularly cardiovascular mortality, according to researchers led by Hans L. Hillege, MD, of the Department of Cardiology at the University Hospital in Groningen, the Netherlands, in a report in this week’s issue of Circulation (Circulation. 2002;106:1777–1782).

In this study by the Prevention of REnal and Vascular ENd stage Disease (PREVEND) group, questionnaires about cardiovascular disease and cardiovascular morbidity, along with a vial to collect an early morning urine sample, were sent to 85 421 inhabitants of Groningen, the Netherlands, between 1997 and 1998. Of those contacted, 40 856 responded and 40 548 were included in the analysis. The urine was used to collect a measurement of urinary albumin concentration.

Later, researchers determined whether the subjects were alive by checking the municipal register. Cause of death was obtained from the Central Bureau of Statistics. During a follow-up period that averaged 961 days, 516 deaths of known cause were recorded for the cohort.

Researchers found a positive dose-response relationship between urinary albumin concentration and mortality. Higher urinary albumin concentration results increased the risk of both cardiovascular and noncardiovascular death after adjustment for other known cardiovascular risk factors. The increases were significantly higher for cardiovascular mortality than for other causes of death. A doubled concentration of urinary albumin was associated with a 1.29 relative risk of cardiovascular mortality and a 1.12 relative risk of death from other causes.

Aspirin or Warfarin: Is There a Better Antithrombotic Therapy?
Warfarin, either alone or in combination with aspirin, was superior to aspirin . . . [Full Text of this Article]